Helius Medical Tech (NASDAQ:HSDT) reported quarterly losses of $(1.30) per share which missed the analyst consensus estimate of $(0.48) by 170.83 percent. This is a 99.66 percent increase over losses of $(382.50) per share from the same period last year. The company reported quarterly sales of $3.620 million which beat the analyst consensus estimate of $3.400 million by 6.47 percent. This is a 7.29K percent increase over sales of $49.000 thousand the same period last year.